Class Action For Recall Of Epinephrine Injector Dismissed By Federal Judge

(August 2, 2016, 12:05 PM EDT) -- CHICAGO — An Illinois federal judge on July 6 dismissed without prejudice a consumer class action for people who purchased the now-recalled Auvi-Q epinephrine injector (Kirstin Maxwell, et al. v. Sanofi-Aventis U.S. LLC, No. 15-10095, N.D. Ill., Eastern Div.; 2016 U.S. Dist. LEXIS 87913).

(Opinion available. Document #28-160804-009Z.)

In 2015, Kirsten Maxwell filed a class action against Sanofi-Aventis U.S. LLC in the U.S. District Court for the Northern District of Illinois, alleging unjust enrichment and deceptive acts and practices under the Illinois Consumer Fraud and Deceptive...
To view the full article, register now.